Investigational Site Number :3920005

Higashiibaraki-gun, Ibaraki 311-3193

0 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma, Plasma Cell Myeloma Recurrent

Studies at this site

• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling